Clinical Determinants of Longitudinal Disability in LGI-1-IgG Autoimmune Encephalitis

BACKGROUND AND OBJECTIVES: Longitudinal outcome studies in leucine-rich glioma inactivated-1 (LGI-1) immunoglobulin G (IgG) autoimmune encephalitis (AE) are needed to inform clinical management and prognostication. This study aims to evaluate longitudinal predictors of disability and disease severit...

Descripción completa

Detalles Bibliográficos
Autores principales: Aboseif, Albert, Li, Yadi, Amin, Moein, Lapin, Brittany, Milinovich, Alex, Abbatemarco, Justin R., Cohen, Jeffrey A., Punia, Vineet, Rae-Grant, Alex D., Galioto, Rachel, Kunchok, Amy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10691218/
https://www.ncbi.nlm.nih.gov/pubmed/37949667
http://dx.doi.org/10.1212/NXI.0000000000200178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10691218/
https://www.ncbi.nlm.nih.gov/pubmed/37949667
http://dx.doi.org/10.1212/NXI.0000000000200178

Ejemplares similares